Review



alpesilib  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress alpesilib
    List of molecular targets identified through MS and STRING analysis.
    Alpesilib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpesilib/product/MedChemExpress
    Average 94 stars, based on 11 article reviews
    alpesilib - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer"

    Article Title: Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer

    Journal: PLOS ONE

    doi: 10.1371/journal.pone.0309491

    List of molecular targets identified through MS and STRING analysis.
    Figure Legend Snippet: List of molecular targets identified through MS and STRING analysis.

    Techniques Used: Clinical Proteomics, Protein-Protein interactions



    Similar Products

    alpesilib  (MedChemExpress)
    94
    MedChemExpress alpesilib
    List of molecular targets identified through MS and STRING analysis.
    Alpesilib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpesilib/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    alpesilib - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    alpesilib  (Novartis)
    90
    Novartis alpesilib
    Liquid Biopsies for therapy guidance towards/against PIK3CA inhibition.
    Alpesilib, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpesilib/product/Novartis
    Average 90 stars, based on 1 article reviews
    alpesilib - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    alpesilib (piqray)  (Novartis)
    90
    Novartis alpesilib (piqray)
    FDA-approved PI3K/Akt/mTOR inhibitors in clinical settings.
    Alpesilib (Piqray), supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alpesilib (piqray)/product/Novartis
    Average 90 stars, based on 1 article reviews
    alpesilib (piqray) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    List of molecular targets identified through MS and STRING analysis.

    Journal: PLOS ONE

    Article Title: Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer

    doi: 10.1371/journal.pone.0309491

    Figure Lengend Snippet: List of molecular targets identified through MS and STRING analysis.

    Article Snippet: JG-98, Ver-155008, Ganetespib, Ipatasertib and Alpesilib were purchased from MedChem Express.

    Techniques: Clinical Proteomics, Protein-Protein interactions

    Liquid Biopsies for therapy guidance towards/against PIK3CA inhibition.

    Journal: Cancers

    Article Title: The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management

    doi: 10.3390/cancers15225463

    Figure Lengend Snippet: Liquid Biopsies for therapy guidance towards/against PIK3CA inhibition.

    Article Snippet: The report of a missing significant OS benefiting from alpesilib treatment [ ] resulted in an interruption of reimbursement for alpesilib in France and alpesilib was withdrawn from the market in Germany on the first of May 2021 by Novartis.

    Techniques: Inhibition, Mutagenesis, Clinical Proteomics, Isolation

    FDA-approved PI3K/Akt/mTOR inhibitors in clinical settings.

    Journal: Drug Discovery Today

    Article Title: The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

    doi: 10.1016/j.drudis.2021.11.002

    Figure Lengend Snippet: FDA-approved PI3K/Akt/mTOR inhibitors in clinical settings.

    Article Snippet: , Alpesilib (Piqray) , Novartis , PI3Kδ isoform , Breast cancer.

    Techniques: